Recurrent Inflammatory Myofibroblastic Tumors

DrugDrug NameDrug Description
DB08865CrizotinibA receptor tyrosine kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) where the tumors have been confirmed to be anaplastic lymphoma kinase (ALK), or ROS1-positive.
DrugDrug NamePhaseStatusCount